Evidence map›Paper›PMID 37291807›Full record

ArticleCell transplantation

Symbiotic Supplementation (

Alejandra Romo-Araiza, Rocío I Picazo-Aguilar, Ernesto Griego, Luis A Márquez, Emilio J Galván, Yolanda Cruz, Ana María Fernández-Presas, Almudena Chávez-Guerra, Roxana Rodríguez-Barrera, Ana P Azpiri-Cardós and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Alejandra Romo-AraizaCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.
Rocío I Picazo-AguilarCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.
Ernesto GriegoDepartamento de Farmacobiología, CINVESTAV Sede Sur, Ciudad de México, México.
Luis A MárquezDepartamento de Farmacobiología, CINVESTAV Sede Sur, Ciudad de México, México.
Emilio J GalvánDepartamento de Farmacobiología, CINVESTAV Sede Sur, Ciudad de México, México.
Yolanda CruzCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.
Ana María Fernández-PresasDepartamento de Microbiología, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, México.
Almudena Chávez-GuerraCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.
Roxana Rodríguez-BarreraCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.
Ana P Azpiri-CardósCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.
Claudia Rosas-QuinteroCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.
Ricardo Jasso-ChávezDepartamento de Bioquímica, Instituto Nacional de Cardiología, Ciudad de México, México.
Cesar V BorlonganCenter of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Antonio IbarraCentro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, México.ORCID 0000-0003-2489-4689
Universidad Anáhuac · MXCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXInstituto Nacional de Cardiologia · BRUniversidad Nacional Autónoma de México · MXUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity has been linked to cognitive impairment through systemic low-grade inflammation. High fat and sugar diets (HFSDs) also induce systemic inflammation, either by induced Toll-like receptor 4 response, or by causing dysbiosis. This study aimed to evaluate the effect of symbiotics supplementation on spatial and working memory, butyrate concentration, neurogenesis, and electrophysiological recovery of HFSD-fed rats. In a first experiment, Sprague-Dawley male rats were given HFSD for 10 weeks, after which they were randomized into 2 groups (

Indexed as

AgaveSpatial MemoryAnimalsDietary SupplementsHippocampusInflammationInulinMaleMaze LearningNeuronal PlasticityObesityRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateInulinReceptors, N-Methyl-D-Aspartatecognitive impairmentLTPmemoryobesitysymbiotics

Identifiers

PMID37291807
PMCPMC10272678
OpenAlexW4379967218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.